NCT05361499View on ClinicalTrials.gov

A Controlled Human Pneumococcal Infection Model (PIM) Study

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2022

Primary Completion Date

February 16, 2023

Study Completion Date

February 16, 2023

Conditions
Streptococcus Pneumoniae Infection
Interventions
BIOLOGICAL

Sp_6B

Intranasal inoculation of Streptococcus pneumoniae serotype 6B, 160,000 colony forming units (CFU)

DRUG

Amoxicillin 500 mg

Amoxicillin, 7 days, 2x 500 mg

Trial Locations (1)

Unknown

Radboudumc, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER